Comorbidities in the idiopathic pulmonary fibrosis and progressive pulmonary fibrosis trial population: a systematic review and meta-analysis
Background Comorbidities can affect drug tolerability and health outcomes in patients with fibrotic interstitial lung disease. This systematic review and meta-analysis evaluated the types and prevalence of comorbidities amongst participants in pharmaceutical randomised controlled trials (RCTs) of id...
Saved in:
| Main Authors: | Tyson M. Walters, Marcus C.H. Leong, Sydney B. Montesi, Christopher J. Ryerson, Yet H. Khor |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2025-03-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/34/175/240238.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular involvement in idiopathic pulmonary fibrosis
by: Michele Mondoni, et al.
Published: (2024-11-01) -
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis
by: Stefano Kette, et al.
Published: (2025-03-01) -
Smoking and Idiopathic Pulmonary Fibrosis
by: Chad K. Oh, et al.
Published: (2012-01-01) -
A clinical case of idiopathic pulmonary fibrosis against the background of comorbid pathology
by: A. V. Teteneva, et al.
Published: (2021-10-01) -
Prospects for Treatment of Idiopathic Pulmonary Fibrosis
by: R. N. Mustafin
Published: (2022-08-01)